MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Search

Quidel Corp

Fechado

17.31 3.78

Visão Geral

Variação de preço das ações

24h

Atual

Mín

15.42

Máximo

17.46

Indicadores-chave

By Trading Economics

Rendimento

602M

-131M

Vendas

24M

724M

Margem de lucro

-18.062

Funcionários

6,500

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+85.46% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-310M

899M

Abertura anterior

13.53

Fecho anterior

17.31

Quidel Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

1 de abr. de 2026, 22:56 UTC

Notícias Principais

Australian PM Set To Announce Interest-Free Loans For Businesses, Farmers

1 de abr. de 2026, 20:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Extends Deadline on Tender Offer to Acquire Arcellx

1 de abr. de 2026, 23:55 UTC

Conversa de Mercado

Gold Rises on Hopes for Early End to U.S.-Iran Conflict -- Market Talk

1 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Nikkei May Rise on Continued Hopes for U.S. Ending Iran War -- Market Talk

1 de abr. de 2026, 23:23 UTC

Notícias Principais

South Korea Consumer Inflation Accelerates on Mideast Energy Shock -- Update

1 de abr. de 2026, 23:07 UTC

Ganhos

Shake Shack Leans on Loyalty Program and Tech to Drive Growth -- Barrons.com

1 de abr. de 2026, 23:02 UTC

Notícias Principais

South Korea Consumer Inflation Accelerates on Mideast Energy Shock

1 de abr. de 2026, 23:00 UTC

Notícias Principais

S Korea Mar CPI +0.3% on Month; +0.6% Forecast

1 de abr. de 2026, 23:00 UTC

Notícias Principais

S Korea Mar Core CPI +2.2% on Year, +0.1% on Month

1 de abr. de 2026, 23:00 UTC

Notícias Principais

S Korea Mar CPI +2.2% on Year; +2.4% Forecast

1 de abr. de 2026, 22:39 UTC

Ganhos

Nike Can't Fix Its China Problem and That's Tanking Its Stock -- Update

1 de abr. de 2026, 22:08 UTC

Conversa de Mercado

KKR BDC Joins Others in Capping Withdrawals at 5% -- Market Talk

1 de abr. de 2026, 22:00 UTC

Notícias Principais

Mideast War Rekindles Asia Inflation Risk, Says DBS Chief Economist -- Interview

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: Rate Hikes Seem Likely in Japan, Singapore, Australia

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: BOK Could Also Take Proactive Approach Like RBA

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: India Vulnerable to War Imapct on Both Trade, Energy

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: China, Malaysia Looks Relatively Well-Insulated From War Fallout

1 de abr. de 2026, 22:00 UTC

Notícias Principais

DBS Chief Economist: Mideast Crisis Won't Hurt Asia Growth Much, Inflation a Bigger Issue

1 de abr. de 2026, 22:00 UTC

Notícias Principais

Inflationary Impact of Mideast Conflict Seems Inevitable, DBS Group Chief Economist Says

1 de abr. de 2026, 21:56 UTC

Aquisições, Fusões, Aquisições de Empresas

BHP Completes $4.3 Billion Silver Streaming Agreement With Wheaton Precious Metals

1 de abr. de 2026, 21:31 UTC

Notícias Principais

End to Iran War Could Trigger Relief Rally in These 2 Assets -- Barrons.com

1 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

1 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

1 de abr. de 2026, 20:38 UTC

Ganhos

Why Nike Stock Is in 'Penalty Box' After Earnings Beat -- Barrons.com

1 de abr. de 2026, 20:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Arsenal Capital Partners Completes Sale of ATP Adhesive Systems to Henkel

1 de abr. de 2026, 20:16 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead: Tender Offer Extended to Expire at 5 p.m. EDT on April 24 >GILD

1 de abr. de 2026, 20:16 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead: Offer Remains at a Purchase Price of $115.00 per Shr >GILD

1 de abr. de 2026, 20:13 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Extends Tender Offer To Acquire Arcellx >GILD

1 de abr. de 2026, 20:07 UTC

Conversa de Mercado

Mexican Manufacturing Indexes Pick Up in March -- Market Talk

1 de abr. de 2026, 20:07 UTC

Aquisições, Fusões, Aquisições de Empresas

Why 2026 Is Biotech's Comeback Year -- Barrons.com

Comparação entre Pares

Variação de preço

Quidel Corp Previsão

Preço-alvo

By TipRanks

85.46% parte superior

Previsão para 12 meses

Média 30.75 USD  85.46%

Máximo 38 USD

Mínimo 25 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Quidel Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

5 ratings

1

Comprar

3

Manter

1

Vender

Informação Financeira

Custos administrativos e de venda

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

Resultado Operacional

$

Sobre Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat